Basel Medical Group Ltd
BMGL
$0.61
$0.024.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -622.66% | -322.68% | -83.12% | -41.87% | 16.75% |
| Total Depreciation and Amortization | 127.35% | 74.99% | 23.47% | 9.34% | -3.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12,133.49% | 3,321.07% | -235.89% | -267.89% | -385.82% |
| Change in Net Operating Assets | -233,762.50% | -313.82% | -18.22% | -42.51% | -100.79% |
| Cash from Operations | -263.78% | -233.28% | -188.11% | -76.52% | -2.68% |
| Capital Expenditure | -141,841.38% | -63,151.56% | -98.57% | -70.69% | -26.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -141,841.38% | -62,825.00% | 487.14% | 284.48% | -26.09% |
| Total Debt Issued | 932.91% | 370.74% | 160.92% | 177.02% | -- |
| Total Debt Repaid | -231.65% | -634.43% | -212.89% | -416.55% | 0.59% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 751.27% | 2,499.91% | 1,243.02% | 1,203.61% | -67,000.00% |
| Cash from Financing | 1,049.15% | 729.13% | 473.48% | 224.83% | 39.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.44% | 2,886.54% | 1,475.57% | 993.72% | 313.81% |